Low Specificity of PGP9.5 for Detecting Neuroblastoma
Author Information
Author(s): J Gilbert, MD Norris, GM Marshall, M Haber
Primary Institution: Children's Cancer Research Institute, Sydney Children's Hospital
Hypothesis
The study aims to determine the specificity of PGP9.5 gene transcripts for detecting micrometastatic neuroblastoma.
Conclusion
The study found that PGP9.5 expression is present in a significant number of normal blood and bone marrow samples, suggesting it lacks specificity for detecting neuroblastoma.
Supporting Evidence
- PGP9.5 was detected in eight out of ten blood samples and seven out of twelve marrow samples.
- Tyrosine hydroxylase expression was not detected in any normal sample.
- The presence of PGP9.5 in normal tissues could lead to false-positive results in cancer detection.
Takeaway
The PGP9.5 gene is found in many normal cells, which makes it hard to use for finding cancer cells in blood or bone marrow.
Methodology
The study used nested reverse transcription-polymerase chain reaction (RT-PCR) to evaluate PGP9.5 and tyrosine hydroxylase expression in normal blood and bone marrow samples.
Limitations
The study does not address the potential for false negatives in detecting neuroblastoma due to the presence of PGP9.5 in normal tissues.
Participant Demographics
Samples were obtained from healthy volunteers and patients with non-malignant disease.
Want to read the original?
Access the complete publication on the publisher's website